Clinical development plan: (+)-vorozole.
D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004791:Enzyme Inhibitors; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D009374:Neoplasms, Experimental / Q000517:prevention & control*; D051381:Rats; D012107:Research Design; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D014230:Triazoles; C060523:vorozole; D004958:Estradiol